Calls for papers

This page is dedicated to our current Calls for Papers – please see the full list below and link through to the full calls for details. Nature Reviews Immune Inflammation welcomes submissions within the scope of each individual call.

Collection

Cancer Immunotherapy

In recent years, with the rise in cancer incidence and growing demand for personalized medicine, cancer immunotherapy has garnered significant attention as an innovative treatment approach. By activating the patient's own immune system to combat cancer cells, this therapy has become a crucial branch of modern oncology.

Open for submissions
Submission deadline
Ongoing

Collection

Gene Editing and CRISPR Technology

Gene editing is a set of technologies that allow scientists to make precise changes to the DNA within organisms. Among these, CRISPR-Cas9 has emerged as a powerful tool for genome editing due to its simplicity, efficiency, and versatility. This technology enables researchers to add, remove, or alter genetic material at specific locations in the genome, revolutionizing fields from basic research to clinical applications.

Open for submissions
Submission deadline
Ongoing

Collection

Single-Cell and Spatial Transcriptomics

Single-cell and spatial transcriptomics represent cutting-edge technologies that allow researchers to explore gene expression at unprecedented resolution. Single-cell RNA sequencing (scRNA-seq) enables the profiling of individual cells within complex tissues, revealing cell-to-cell variability and identifying rare cell types. Spatial transcriptomics, on the other hand, provides insights into the spatial organization of gene expression within intact tissue sections, preserving the context of cellular interactions.

Open for submissions
Submission deadline
Ongoing

Collection

Artificial Intelligence and Machine Learning in Life Sciences

Artificial intelligence (AI) and machine learning (ML) are transforming the life sciences by enabling researchers to analyze vast amounts of complex data more efficiently and accurately than ever before. These technologies facilitate predictive modeling, pattern recognition, and decision-making processes, providing novel insights into biological systems and accelerating discoveries across various domains.

Open for submissions
Submission deadline
Ongoing

Access rights

Life Conflux is open access. All content is freely available to read, download and share immediately upon publication.

License

Life Conflux is licensed under a Creative Commons Attribution 4.0 International License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Creative Commons License

Copyright

Submission of a manuscript to the Life Conflux journal directly implies that all the authors have read and agreed to the journal's guidelines. The content present in the manuscript after publication will be freely available to all the potential readers over the Internet.

Notice

The content provided by the authors in the manuscript should at no point of time breach the Copyrights or rights of a third party. The manuscript submitted should not be published or submitted for consideration in any other journal. Manuscripts with plagiarized content will not be considered for the peer-review process.

COPE

DigitalObject Unique Identifier

DOI is registered through Crossref to ensure that each content has a unique identifier and supports citation statistics and long-term content preservation.

Crossref

Recent issues

LATEST ISSUE Volume 1, Issue 1 Dec 2024